Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer.
Esther H Lips,
Tapsi Kumar,
Anargyros Megalios,
Lindy L Visser,
Michael Sheinman,
Angelo Fortunato,
Vandna Shah,
Marlous Hoogstraat,
Emi Sei,
Diego Mallo,
Maria Roman-Escorza,
Ahmed A Ahmed,
Mingchu Xu,
Alexandra W van den Belt-Dusebout,
Wim Brugman,
Anna K Casasent,
Karen Clements,
Helen R Davies,
Liping Fu,
Anita Grigoriadis,
Timothy M Hardman,
Lorraine M King,
Marielle Krete,
Petra Kristel,
Michiel de Maaker,
Carlo C Maley,
Jeffrey R Marks,
Brian A Menegaz,
Lennart Mulder,
Frank Nieboer,
Salpie Nowinski,
Sarah Pinder,
Jelmar Quist,
Carolina Salinas-Souza,
Michael Schaapveld,
Marjanka K Schmidt,
Abeer M Shaaban,
Rana Shami,
Mathini Sridharan,
John Zhang,
Hilary Stobart,
Deborah Collyar,
Serena Nik-Zainal,
Lodewyk FA Wessels,
E Shelley Hwang,
Nicholas E Navin,
P Andrew Futreal,
Grand Challenge PRECISION consortium,
Alastair M Thompson,
Jelle Wesseling,
Elinor J Sawyer
Jul 10, 2022
Ductal carcinoma in situ (DCIS) is the most common form of preinvasive breast cancer and, despite treatment, a small fraction (5-10%) of DCIS patients develop subsequent invasive disease. A fundamental biologic question is...